We are live on ! Find out more
SCM

Suffolk Capital Management Portfolio holdings

AUM $521M
1-Year Est. Return 9.79%
This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
-9.79%
3 Year Est. Return
+48.57%
5 Year Est. Return
+94.78%
10 Year Est. Return
AUM
$776M
AUM Growth
+$22.1M
Cap. Flow
+$8.34M
Cap. Flow %
1.07%
Top 10 Hldgs %
19.79%
Holding
170
New
32
Increased
55
Reduced
45
Closed
32

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$13.3M
2
LOW icon
Lowe's Companies
LOW
+$11.8M
3
BNY
Bank of New York Mellon
BNY
+$11.7M
4
ACM icon
Aecom
ACM
+$11.5M
5
UNP icon
Union Pacific
UNP
+$10.8M

Sector Composition

Rank Sector Weight
1 Healthcare 17.57%
2 Technology 17.31%
3 Industrials 15.94%
4 Consumer Discretionary 14.5%
5 Financials 10.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
101
AbbVie
ABBV
$465B
$2.34M 0.3%
+37,733
New +$2.3M
IDTI
102
DELISTED
Integrated Device Technology I
IDTI
$2.33M 0.3%
115,773
+21,722
+23% +$460K
CSOD
103
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$2.32M 0.3%
60,986
-15,897
-21% -$592K
TMH
104
DELISTED
Team Health Holdings Inc
TMH
$2.32M 0.3%
57,058
+2,398
+4% +$105K
BWLD
105
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$2.31M 0.3%
16,645
+2,155
+15% +$305K
ZEN
106
DELISTED
ZENDESK INC
ZEN
$2.31M 0.3%
+87,614
New +$2.12M
CAVM
107
DELISTED
Cavium, Inc.
CAVM
$2.31M 0.3%
59,881
+20,059
+50% +$992K
CPHD
108
DELISTED
Cepheid Inc
CPHD
$2.28M 0.29%
74,156
+2,429
+3% +$73.4K
JACK icon
109
Jack in the Box
JACK
$314M
$2.24M 0.29%
26,078
-2,037
-7% -$154K
ZLTQ
110
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$2.22M 0.29%
81,335
+15,768
+24% +$444K
PLNT icon
111
Planet Fitness
PLNT
$4.45B
$2.21M 0.28%
117,117
-35,179
-23% -$593K
RVNC
112
DELISTED
Revance Therapeutics, Inc.
RVNC
$2.16M 0.28%
158,812
+62,341
+65% +$1.1M
AERI
113
DELISTED
Aerie Pharmaceuticals
AERI
$2.09M 0.27%
+119,005
New +$1.93M
CLDX icon
114
Celldex Therapeutics
CLDX
$2.94B
$2.08M 0.27%
31,653
+2,578
+9% +$164K
T icon
115
AT&T
T
$164B
$2.02M 0.26%
61,962
-138,270
-69% -$4.11M
ATRO icon
116
Astronics
ATRO
$3.21B
$1.98M 0.25%
94,277
-5,030
-5% -$116K
CIEN icon
117
Ciena
CIEN
$46.8B
$1.98M 0.25%
105,329
-20,090
-16% -$364K
INFN
118
DELISTED
Infinera Corporation Common Stock
INFN
$1.97M 0.25%
175,023
+12,795
+8% +$167K
KTWO
119
DELISTED
K2M Group Holdings, Inc
KTWO
$1.97M 0.25%
+126,881
New +$1.79M
ECHO
120
DELISTED
Echo Global Logistics, Inc.
ECHO
$1.68M 0.22%
+75,112
New +$1.77M
TYL icon
121
Tyler Technologies
TYL
$13.7B
$1.65M 0.21%
9,906
-11,030
-53% -$1.63M
BURL icon
122
Burlington
BURL
$23.4B
$1.6M 0.21%
24,017
-18,412
-43% -$1.08M
MGNX icon
123
MacroGenics
MGNX
$233M
$1.57M 0.2%
58,010
-35,241
-38% -$795K
GWRE icon
124
Guidewire Software
GWRE
$13.9B
$1.56M 0.2%
25,226
-17,464
-41% -$1.01M
FARO
125
DELISTED
Faro Technologies
FARO
$1.55M 0.2%
45,712
-23,700
-34% -$784K

Similar funds

Suffolk Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Suffolk Capital Management held 170 positions worth $776M, up 2.9% from $754M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Suffolk Capital Management's Q2 2016 filing shows 32 new, 55 increased, 45 reduced and 32 closed positions. Its largest new stake was Humana: 74,931 shares worth $13.5M. The largest sale was Apple, an estimated $16.6M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.

  • Suffolk Capital Management's largest Q2 2016 buy was Humana: 74,931 shares worth $13.5M.
  • Suffolk Capital Management added most to Allergan plc in Q2 2016, an estimated $9.01M increase.
  • Suffolk Capital Management's biggest Q2 2016 reduction was Apple, cutting an estimated $16.6M.
  • Suffolk Capital Management fully exited Cigna in Q2 2016, selling an estimated $13.5M.
  • Suffolk Capital Management's ten largest holdings make up 20% of its $776M portfolio in Q2 2016.
  • Suffolk Capital Management opened 32 new positions and closed 32 in Q2 2016.
  • Suffolk Capital Management's portfolio value rose 2.9% quarter-over-quarter to $776M.

Based on Suffolk Capital Management's 13F filing for Q2 2016, filed 8 Aug 2016.